BAILEY MOORE: Open Payments
NPI 1790441533 · CROSSVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,455 in 55 payments from 14 companies in 2025. Trend: 2023 $56 · 2024 $391 · 2025 $2,455
Food & beverage: $1,330Consulting: $1,125
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $1,452 |
| ABBVIE INC. | 7 | $255 |
| Galderma Laboratories, L.P. | 6 | $213 |
| Lilly USA, LLC | 13 | $186 |
| GENZYME CORPORATION | 2 | $59 |
| UCB, Inc. | 2 | $45 |
| Incyte Corporation | 2 | $45 |
| Arcutis Biotherapeutics, Inc. | 3 | $45 |
| Kerecis Limited | 2 | $37 |
| Smith+Nephew, Inc. | 1 | $27 |
Products named: TREMFYA, NEMLUVIO, SKYRIZI, TALTZ, EBGLYSS, DUPIXENT, Bimzelx, OPZELURA.
Industry payments across TN — which companies pay providers there.
